Literature DB >> 14741154

Stability of mono- and trivalent meningococcal outer membrane vesicle vaccines.

Carmen Arigita1, Wim Jiskoot, Janny Westdijk, Cor van Ingen, Wim E Hennink, Daan J A Crommelin, Gideon F A Kersten.   

Abstract

The stability during storage of outer membrane vesicles (OMVs) of Neisseria meningitidis group B was studied. Three types of OMVs were compared for their stability, containing either one (monovalent) or three different PorA subtypes (trivalent), the latter with and without class 4 outer membrane protein (OMO, RmpM). Aqueous formulations were stored freeze-dried (4 degrees C), frozen (-70 degrees C) and in liquid form at 4, 37 and 56 degrees C. Physico-chemical properties and immunogenicity of the OMVs as well as PorA conformation and antigenicity (P1.7-2,4, the subtype present in all formulations) were monitored during 1 year. At -70 or 4 degrees C, the structure and immunogenicity of OMVs was preserved. Storage of OMVs at high temperatures (37 or 56 degrees C) induced destruction of the OMV structure and denaturation of PorA, followed by chemical degradation. Immunogenicity decreased or was lost completely. Changes observed in the fluorescence spectra of degraded OMVs were also seen in tryptophan (Trp) and tyrosine (Tyr) derivatives incubated at 56 degrees C, indicating the occurrence of chemical degradation of tryptophan and tyrosine residues in PorA. Trivalent OMVs were slightly more stable at 37 degrees C than monovalent OMVs as assessed by in vitro methods, but these differences did not result in differences in the immunogenicity. The stability of trivalent OMVs was not affected by the presence of RmpM. Both trivalent and monovalent OMVs could be freeze-dried with preservation of their immunogenicity. In conclusion, OMVs are sensitive to elevated temperatures, but are stable in the frozen or freeze-dried state or when stored at 4 degrees C in the liquid state.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14741154     DOI: 10.1016/j.vaccine.2003.08.027

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  22 in total

1.  Delivery of foreign antigens by engineered outer membrane vesicle vaccines.

Authors:  David J Chen; Nikolaus Osterrieder; Stephan M Metzger; Elizabeth Buckles; Anne M Doody; Matthew P DeLisa; David Putnam
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-27       Impact factor: 11.205

Review 2.  Immune modulation by bacterial outer membrane vesicles.

Authors:  Maria Kaparakis-Liaskos; Richard L Ferrero
Journal:  Nat Rev Immunol       Date:  2015-05-15       Impact factor: 53.106

3.  Pathogenesis Mediated by Bacterial Membrane Vesicles.

Authors:  William J Gilmore; Natalie J Bitto; Maria Kaparakis-Liaskos
Journal:  Subcell Biochem       Date:  2021

Review 4.  Outer membrane vesicles in service as protein shuttles, biotic defenders, and immunological doppelgängers.

Authors:  Richard C Laughlin; Robert C Alaniz
Journal:  Gut Microbes       Date:  2016-08-15

5.  Immunoactive Clostridial Membrane Vesicle Production Is Regulated by a Sporulation Factor.

Authors:  Nozomu Obana; Ryoma Nakao; Kyoko Nagayama; Kouji Nakamura; Hidenobu Senpuku; Nobuhiko Nomura
Journal:  Infect Immun       Date:  2017-04-21       Impact factor: 3.441

6.  Production, Isolation, and Characterization of Bioengineered Bacterial Extracellular Membrane Vesicles Derived from Bacteroides thetaiotaomicron and Their Use in Vaccine Development.

Authors:  Régis Stentz; Ariadna Miquel-Clopés; Simon R Carding
Journal:  Methods Mol Biol       Date:  2022

7.  Effect of the Freezing Step in the Stability and Bioactivity of Protein-Loaded PLGA Nanoparticles Upon Lyophilization.

Authors:  Pedro Fonte; Fernanda Andrade; Cláudia Azevedo; João Pinto; Vítor Seabra; Marco van de Weert; Salette Reis; Bruno Sarmento
Journal:  Pharm Res       Date:  2016-07-21       Impact factor: 4.200

8.  Coincorporation of LpxL1 and PagL mutant lipopolysaccharides into liposomes with Neisseria meningitidis opacity protein: influence on endotoxic and adjuvant activity.

Authors:  Jesús Arenas; Harry van Dijken; Betsy Kuipers; Hendrik Jan Hamstra; Jan Tommassen; Peter van der Ley
Journal:  Clin Vaccine Immunol       Date:  2010-01-27

Review 9.  Microbiota-host communications: Bacterial extracellular vesicles as a common language.

Authors:  Rogers A Ñahui Palomino; Christophe Vanpouille; Paolo E Costantini; Leonid Margolis
Journal:  PLoS Pathog       Date:  2021-05-13       Impact factor: 6.823

10.  Improved production process for native outer membrane vesicle vaccine against Neisseria meningitidis.

Authors:  Bas van de Waterbeemd; Gijsbert Zomer; Patricia Kaaijk; Nicole Ruiterkamp; René H Wijffels; Germie P J M van den Dobbelsteen; Leo A van der Pol
Journal:  PLoS One       Date:  2013-05-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.